Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration

Abstract Background Type 2 macular neovascularization (MNV) is supposed to be a rare condition in age-related macular degeneration (AMD). The main purpose of this study was to assess accompanying factors of type 2 MNV in AMD. Methods Retrospective data analysis of eyes previously diagnosed with neov...

Full description

Bibliographic Details
Main Authors:	Daniel Ahmed, Martin Stattin, Anna-Maria Haas, Alexandra Graf, Katharina Krepler, Siamak Ansari-Shahrezaei
Format:	Article
Language:	English
Published:	BMC 2020-09-01
Series:	BMC Ophthalmology
Subjects:	Age-related macular degeneration Type 2 macular neovascularization Drusen Subretinal drusenoid deposits
Online Access:	http://link.springer.com/article/10.1186/s12886-020-01651-2

Similar Items

Inner Retinal Layer Thickness Alterations in Early Age Related Macular Degeneration in Eyes with Subretinal Drusenoid Deposits or Conventional Drusen
by: Solmaz Abdolrahimzadeh, et al.
Published: (2021-10-01)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
by: Shruti Chandra, et al.
Published: (2023-02-01)

Reticular Pseudodrusen: Interreader Agreement of Evaluation on OCT Imaging in Age-Related Macular Degeneration
by: Zhichao Wu, BAppSc(Optom), PhD, et al.
Published: (2023-12-01)

Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
by: Dongwan Kang, et al.
Published: (2022-07-01)

Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration
by: Cynthia Owsley, PhD, MSPH, et al.
Published: (2023-06-01)

Association between Subretinal Drusenoid Deposits and Age-Related Macular Degeneration in Multimodal Retinal Imaging
by: Elżbieta Krytkowska, et al.
Published: (2023-12-01)

Subretinal drusenoid deposits versus drusen on multicolor imaging
by: Ramesh Venkatesh, et al.
Published: (2020-01-01)

Reticular Pseudodrusen Voids after Rhegmatogenous Retinal Detachment
by: Vegard Asgeir Forsaa, et al.
Published: (2023-08-01)

LASER PHOTOCOAGULATION OF SOFT MACULAR DRUSEN
by: L. I. Balashevich, et al.
Published: (2015-12-01)

Laser photocoagulation of soft macular drusen
by: L.I. Balashevich, et al.
Published: (2013-03-01)

Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry
by: Shrinivas Joshi, et al.
Published: (2023-01-01)

Morphological changes of macular soft drusen and drusenoid DPED after subthreshold micropulse laser treatment
by: Qing-Shan Chen, et al.
Published: (2020-06-01)

A Pilot Study Evaluating the Effects of 670 nm Photobiomodulation in Healthy Ageing and Age-Related Macular Degeneration
by: Manjot K. Grewal, et al.
Published: (2020-04-01)

Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
by: Jing Wu, et al.
Published: (2022-04-01)

Epidemiological profile of age-related macular degeneration patients in Federal University of Parana, Brazil
by: Fernando Morandini Pradella, et al.

Analyses of the effects of persistent subretinal fluid on visual/anatomic outcomes according to the type of macular neovascularization during the relaxed treat-and-extend protocol in age-related macular degeneration patients
by: Kyung Tae Kim, et al.
Published: (2021-08-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Subretinal drusenoid deposits: An update
by: Manuel Monge, et al.
Published: (2022-01-01)

Changes of drusen number and central retinal thickness in age-related macular degeneration patients over two years
by: Krešimir Mandić, et al.
Published: (2016-01-01)

Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
by: Daniel Ahmed, et al.
Published: (2020-10-01)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
by: Sayah DN, et al.
Published: (2023-12-01)

Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration
by: Amy C. Cohn, et al.
Published: (2021-01-01)

Prevalence of age-related macular degeneration among elderly patients attending Alexandria Main University Hospital
by: Alaa M Fadel, et al.
Published: (2016-01-01)

Lysolipids are prominent in subretinal drusenoid deposits, a high-risk phenotype in age-related macular degeneration
by: David M. G. Anderson, et al.
Published: (2023-11-01)

Quantitative proteomic analysis of aqueous humor from patients with drusen and reticular pseudodrusen in age-related macular degeneration
by: Je-Hyun Baek, et al.
Published: (2018-11-01)

Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
by: Helene O. Larsen, et al.
Published: (2023-07-01)

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification
by: Daniel Rudolf Muth, et al.
Published: (2022-09-01)

Multimodal Imaging and En Face OCT Detection of Calcified Drusen in Eyes with Age-Related Macular Degeneration
by: Jeremy Liu, BS, et al.
Published: (2022-06-01)

Dark Adaptation and Its Role in Age-Related Macular Degeneration
by: Archana K. Nigalye, et al.
Published: (2022-03-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Early Stages of Age-Related Macular Degeneration: Racial/Ethnic Differences and Proposal of a New Classification Incorporating Emerging Concept of Choroidal Pathology
by: Mariko Sasaki, et al.
Published: (2022-10-01)

Complete Resolution of Central Soft Drusen without Geographic Atrophy or Choroidal Neovascularization
by: Rebecca Zeng, et al.
Published: (2022-03-01)

Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration
by: Michael Karampelas, et al.
Published: (2020-08-01)

Intravitreal Ranibizumab for Subfoveal Choroidal Neovascularization from Age-Related Macular Degeneration with Combined Severe Diabetic Retinopathy
by: So Young Han, et al.
Published: (2015-02-01)

Low-Reflectivity Drusen With Overlying RPE Damage Revealed by Spectral-Domain OCT: Hint for the Development of Age-Related Macular Degeneration
by: Shasha Yang, et al.
Published: (2021-10-01)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021-06-01)

AI-based support for optical coherence tomography in age-related macular degeneration
by: Virginia Mares, et al.
Published: (2024-04-01)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
by: Akira Hirata, et al.
Published: (2018-03-01)

Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis
by: Pengxiang Zhou, et al.
Published: (2021-10-01)